Oleandomycin
Systematic (IUPAC) name | |
---|---|
(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15-hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 3922-90-5 |
ATC code | J01FA05 |
PubChem | CID 5284598 |
ChemSpider | 4447646 |
UNII | P8ZQ646136 |
ChEMBL | CHEMBL606258 |
Chemical data | |
Formula | C35H61NO12 |
Molar mass | 687.858 g/mol |
| |
| |
(what is this?) (verify) |
Oleandomycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces antibioticus. It is weaker than erythromycin.
It used to be sold under the brand name Sigmamycine, combined with tetracycline, and made by the company Rosa-Phytopharma in France.
|
This article is issued from Wikipedia - version of the Thursday, October 30, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.